biosimilar

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

Biocon Biologics secures EU nod for two Denosumab biosimilars, expanding bone health treatment access in Europe.

Biocon Biologics gets EU approval for 2 drugs to treat bone cancer, osteoporosis and bone loss

Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and Evfraxy, expanding treatment…

July 3, 2025 11:08 IST

Nothing Phone 3 India price leaked online: Check launch date, design, camera colour options and more specs here

Nothing recently released a brief teaser video titled, “Goodbye Glyph Interface,” suggesting that the upcoming Phone (3) will do away…

June 3, 2025 11:30 IST

Health Canada gives nod to Lupin’s biosimilar to treat infection in cancer patients

The drug is used to reduce the chance of infection in people who have certain types of cancer and are…

August 23, 2024 14:11 IST

Amgen, Biosimilars, Inflammatory diseases, USFDA, USFDA news, healthcare news, pharma news,

USFDA approves Amgen’s biosimilar for multiple inflammatory diseases

Wezlana must be dispensed with a patient Medication Guide that describes important information about its uses and risks, USFDA stated.

November 1, 2023 13:23 IST

healthcare revolution, health news, pharma news,

Sandoz gets USFDA approval for its biosimilar to treat relapsing forms of multiple sclerosis

Sandoz entered into a global commercialization agreement for Tyruko with Polpharma Biologics in 2019. Under this agreement, Polpharma Biologics will…

August 25, 2023 13:00 IST

ABB India, Reliance Life Sciences, automation, biopharmaceutical, control solutions, manufacturing plants, technology, IT footprint, costs

ABB India secures order for automating Reliance Life Sciences’ biopharmaceutical facilities

The scope encompasses complete automation of the manufacturing process using ABB’s flagship Distributed Control System (DCS) Ability™ System 800xA, Remote…

August 22, 2023 07:45 IST

Can partnerships with CRDMOs boost biosimilar manufacturing?

The biosimilar manufacturing market is dominated by western companies and in Asia Biocon Biologics is growing strong and has joined…

April 2, 2023 12:00 IST

Meteoric Pharmaceuticals, Biopharmaceuticals, biosimilars, health news, pharma news,

India is on cusp of massive leap towards being global biopharma leader: Gaurav Kaushik, Meteoric Biopharmaceuticals

Bio-pharma industry, albeit slow in adopting digital intervention, is now opening up to new-age automation technologies, Kaushik told Financial Express.com.

December 31, 2022 10:00 IST

Dr. Reddy's, Dr Reddy's labs, Difluprednate Ophthalmic Emulsion, eye drops, eye care, health news, pharma news,

Dr. Reddy’s Labs’ biosimilar candidate for arthritis drug shows positive outcome in Phase I study

According to the company, it is developing the proposed tocilizumab biosimilar as both subcutaneous and intravenous formulations.

December 19, 2022 13:38 IST

Novartis, Heart failure, patent expiry, Indian cardiac market, healthcare news, pharma news,

Some Biosimilar products help in increasing neutrophil counts of cancer patients, which helps to boost the immune system and reduce…

December 18, 2022 20:41 IST

Lupin, Lupin Limited, Sildenafil, erectile dysfunction, Pfizer, Viagra, Health news, pharma news,

Lupin receives Health Canada approval for its biosimilar Rymti

Rymti is a biosimilar of Etanercept which is an injectable, biologic medicine that inhibits Tumour Necrosis Factor (TNF)

September 13, 2022 15:07 IST

Lupin, Sunovion, inhalation brands, health news, pharma news,

Lupin and I’rom enter into exclusive licensing agreement for Denosumab biosimilar in Japan

The company stated that following the completion of the clinical trial and receipt of marketing authorization from PMDA in Japan,…

August 25, 2022 11:33 IST

Biocon Biologics, Viatris, Biosimilars, definitive agreement, CCPS, Serum Institute Life Sciences, Kiran Mazumdar Shaw

Biocon Biologics to acquire Viatris’ Biosimilars for up to USD 3.3 billion in stock and cash

The acquisition of biosimilars assets of Viatris significantly strengthens BBL’s position in providing affordable access to patients through its portfolio…

Updated: February 28, 2022 11:31 IST

Dr Reddy’s and TR-Pharm in agreement

TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey

March 11, 2016 15:33 IST

Generic opportunities outweigh challenges emanating across emerging markets: ICRA

Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India have achieved a CAGR…

September 16, 2015 16:50 IST

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative condition of the eyes…

June 22, 2015 15:51 IST

Syngene seeks approval for IPO, files DRHP

Offer allows Biocon to monetise its shareholding in Syngene

April 29, 2015 09:40 IST

Related News

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Gold Hits All-Time High of $4,000/oz Globally; Experts Warn of Imminent Correction After 37.5% India Rally.

Gold prices may see a sharp correction

H-1B, OPT program, foreign workers, foreign students, H-1B petition fees, Optional Practical Training program

After H-1B, the OPT program for foreign students under threat

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

‘They started this thing’: Trump blames Democrats as White House lays off thousands

World News32 min ago

President Trump is accusing Democrats of being responsible for the thousands of federal worker layoffs during the government shutdown. Around 300,000 workers are already set to leave due to downsizing efforts, and Trump has threatened to fire even more, specifically targeting agencies supported by Democrats. Despite pressure, Democrats are refusing to give in, while unions are taking legal action.

View all shorts